Results 261 to 270 of about 377,496 (294)

Characterizing the Emergence of Myeloid-Derived Suppressor Cell Subsets in a Murine Model of Pulmonary Fibrosis. [PDF]

FASEB J
Vedder N, Gercke P, Lautenschlager N, Brunn T, Lange T, Schieb J, Vetter C, van Geffen C, Kolahian S.   +8 more
europepmc   +1 more source

Go to the scene: T_H9 cells superior migration ability to the lungs explains their exceptional anticancer efficacy. [PDF]

J Immunother Cancer
Xu J, Apetoh L.
europepmc   +1 more source

CD4⁺CD25⁺ regulatory T cell therapy in neurological autoimmune diseases. [PDF]

PeerJ
Yuan G, Liu Y, Wang H, Yang T, Liu G.
europepmc   +1 more source

Regulatory B cells attenuate sepsis-associated pancreatic injury by regulating T cell homeostasis. [PDF]

Sci Rep
Liu P, Xiao Z, Lu X, Zhang X, Huang J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Adoptive cell transfer therapy for melanoma

Experimental Dermatology, 2022
Adoptive cell transfer (ACT) of tumor‐infiltrating lymphocytes (TILs) for melanoma is an example of the most successful cancer immune therapy. It achieves a durable complete response about ~20% of patients, and they might be cured.
T. Inozume
semanticscholar   +1 more source

Nanovaccine‐Mediated Cell Selective Delivery of Neoantigens Potentiating Adoptive Dendritic Cell Transfer for Personalized Immunization

Advanced Functional Materials, 2021
Neoantigen vaccines and adoptive dendritic cell (DC) transfer are major clinical approaches to initiate personalized immunity in cancer patients. However, the immunization efficacy is largely limited by the in vivo trajectory including neoantigens ...
Ping Xiao, Jue Wang, Lei Fang, Zitong Zhao, Xiangshi Sun, Xiaochen Liu, Hai-qiang Cao, Pengcheng Zhang, Dangge Wang, Yaping Li   +9 more
semanticscholar   +1 more source

Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma.

Journal of Clinical Oncology, 2019
2538 Background: There is a high unmet medical need for effective treatments for patients with recurrent, metastatic, or persistent cervical cancer. Most patients are young and survival rates are poor.
A. Jazaeri, E. Zsiros, R. Amaria, A. Artz, R. Edwards, R. Wenham, B. Slomovitz, A. Walther, Sajev Thomas, J. Chesney, R. Morris, K. Matsuo, S. Gaillard, P. Rose, J. G. Donas, J. Tromp, F. Tavakkoli, Huiling Li, M. Fardis, B. Monk   +19 more
semanticscholar   +1 more source

Recent advances in biomaterial-boosted adoptive cell therapy.

Chemical Society Reviews, 2022
Adoptive immunotherapies based on the transfer of functional immune cells hold great promise in treating a wide range of malignant diseases, especially cancers, autoimmune diseases, and infectious diseases.
Yonger Xue, Junyi Che, Xuemei Ji, Yunuo Li, Jinbing Xie, Xiaoyuan Chen   +5 more
semanticscholar   +1 more source

Adoptive Cell Transfer

International Review of Cell and Molecular Biology, 2022

semanticscholar   +1 more source

A Comprehensive Survey on Transfer Learning

Proceedings of the IEEE, 2021
Dongbo Xi, Fuzhen Zhuang, Zhiyuan Qi
exaly